Here, we identified fibulin-4 (FBLN4), also known as EFEMP2, as the protein target for BLMP6 binding and show that FBLN4 is highly expressed in invasive and metastatic human breast cancer. The gene discussed is EFEMP2; the disease is breast cancer.